Tag: #Global Trends

Global contract research organization (CRO) Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research. The... Read more

In a significant corporate reshuffle, Japanese pharmaceutical firm Shionogi & Co. has committed an additional $2.13 billion to increase its... Read more

In its first major M&A move under new CEO Luke Miels, GSK has reached a definitive agreement to acquire California-based... Read more

U.S. pharmaceutical giant Pfizer has agreed to divest its entire interest in ViiV Healthcare, a global specialist in HIV treatment,... Read more

The French biotech firm Valneva has announced the permanent withdrawal of its chikungunya vaccine, Ixchiq, from the United States. This... Read more

Pharmaceutical giant Takeda is implementing a new round of job cuts in the United States as it prepares for the... Read more

Pharmaceutical giant GSK is undertaking a strategic move to optimize the administration of its flagship immunotherapy through a new technological... Read more

Recognition from U.S. regulatory authorities On January 19, 2026, the U.S. Food and Drug Administration (FDA) officially granted "Breakthrough Therapy"... Read more

Signals of a capital market recovery The beginning of 2026 has witnessed signs of a resurgence in the biotech IPO... Read more